Company: RGNT
Filing Date: 2025-05-05
Form Type: F-1/A
Source: 0001213900-25-039589
Chunk: 266

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-05-05
Form: F-1/A
Chunk 266
---
 unless previously converted (see below), shall become fully due and payable in cash following one (1) year from each 2020 CLA issuance
date. The 2020 Notes may be converted into the most senior securities of the Company or repaid as follows:

| 1. | Automatic conversion upon occurrence of a qualified round – upon the closing of a qualified                                            
 round (transaction or series of related transactions in which shares of the Company having substantially similar rights are issued     
 for an aggregate investment amount of at least $ 3,000), the 2020 Notes shall be automatically be converted into such number of shares 
 of the most senior securities issued in such qualified round, based on a price per share equal to 80% of the lowest price per share    
 actually paid by any investor in the qualified round.                                                                                  |

<div align='center'>F-16</div>

REGENTIS BIOMATERIALS LTD.

NOTES TO FINANCIAL STATEMENTS

U.S. dollars in thousands, except share and per share data

| NOTE 6:- | CONVERTIBLE NOTES (Cont.) |

| 2. | Automatic conversion upon occurrence of a merger and acquisition transaction – upon the                                           
 closing of merger and acquisition transaction (as defined in the 2020 CLAs), the 2020 Notes shall be automatically converted into 
 Company’s most senior securities, based on a price per share equal to 80% of the lowest price per attributed to such securities   
 in the merger and acquisition transaction.                                                                                        |

In October 2021, the Company and
2020 CLA investors reached an agreement according to which, in connection with the raising of the 2021 Notes, the 2020 Notes will be
converted into Ordinary Shares upon the occurrence of an exit event (including an IPO or merger) of the Company based
on a price per share equal to 80% at a pre money valuation of $5,150.

On January 3, 2024, the Company
extended the due date of the 2020 Notes until April 30, 2024 and, subsequently, on April 26, 2024, further extended the due date until
May 27, 2024.

| b. | In October 2024,                                                                                 
 the Company entered into an addendum to the 2020 CLAs (the “October 2024 CLA Addendum”)          
 pursuant to which the Company will issue additional notes up to an additional aggregate amount   
 of $450 to certain lenders